SCHEMBL6284403

SCHEMBL6284403

Fc1cc(F)c(F)c(Nc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.44
HSD17B10 Q99714 3/20 0.42
MAPT P10636 7/20 0.42
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
GAA P10253 6/20 0.42
KDM4E B2RXH2 5/20 0.42
TDP1 Q9NUW8 4/20 0.42
GLA P06280 2/20 0.42
RECQL P46063 1/20 0.42
ALDH1A1 P00352 7/20 0.41
AR P10275 1/20 0.41
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALOX15 P16050 3/20 0.41
MAPK1 P28482 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1769240 0.82 HSD17B10 (0.44) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL13042657 0.78 RAB9A (0.59) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL23830066 0.77 MAPT (0.36) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL1118486 0.75 KMT2A (0.56) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL21052247 0.74 HSD17B10 (0.57) GRM4HSD17B10MAPTMEN1KMT2A
SCHEMBL29240832 0.72 HSD17B10 (0.48) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL6284261 0.72 GRM4 (0.41) GRM4MAPK14
SCHEMBL1704615 0.72 MAPT (0.56) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL1118796 0.72 HSD17B10 (0.60) HSD17B10MAPTMEN1KMT2AGAA
SCHEMBL30785818 0.72 MAPT (0.56) HSD17B10MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919291-B2 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-07-19 US disclosed
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2004-06-10 US disclosed
EP-1349653-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2003-10-08 EP disclosed
WO-2002036639-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization FZD7, FOS, COG4 GRM4 2712/4885HSD17B10 3121/4885MAPT 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.